Last reviewed · How we verify

NCT03874598: EOMI

Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer

Completed NA Last updated 24 May 2021
What this trial tests

NA trial testing Ear acupuncture in Breast Neoplasm in 52 participants. Completed in 19 February 2020.

Timeline
12 June 2019
Primary endpoint
19 February 2020
19 February 2020

Quick facts

Lead sponsorUniversität Duisburg-Essen
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment52
Start date12 June 2019
Primary completion19 February 2020
Estimated completion19 February 2020
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Universität Duisburg-Essen — full company profile →

Who can join

Adults 18 to 75, female only, with Breast Neoplasm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical study is to investigate the extent to which ear acupuncture has an effect on insomnia in women with breast cancer. It will be investigated whether changes in sleep quality, fatigue, quality of life, stress, and psychological well-being can be achieved. In addition, a proinflammatory cytokine will be meassured.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy and Safety of Auricular Acupuncture for the Treatment of Insomnia in Breast Cancer Survivors: A Randomized Controlled Trial.
    Höxtermann MD, Buner K, Haller H, Kohl W, et al · · 2021 · cited 34× · PMID 34439234 · DOI 10.3390/cancers13164082

Verify or expand the search:

Other trials of Ear acupuncture

Trials testing the same drug.

Other recruiting trials for Breast Neoplasm

Currently open trials in the same condition.

Other Universität Duisburg-Essen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03874598.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing